Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Gut microbiome and immune checkpoint inhibitor toxicity

Title: Gut microbiome and immune checkpoint inhibitor toxicity
Authors: Verheijden, Rik J; van Eijs, Mick J M; Paganelli, Fernanda L; Viveen, Marco C; Rogers, Malbert R C; Top, Janetta; May, Anne M; van de Wijgert, Janneke H H M; Suijkerbuijk, Karijn P M; UNICIT consortium; MS Medische Oncologie; Cancer; Epi Kanker; MMB; JC onderzoeksprogramma Cancer; CTI; MMB-mcb; Infection & Immunity; Epi Infectieziekten Team 1b; JC onderzoeksprogramma Infectious Diseases
Publication Year: 2025
Subject Terms: Checkpoint inhibitor; Immune-related adverse event; Microbiome; Toxicity; Oncology; Cancer Research
Description: BACKGROUND: Multiple studies have suggested that gut microbiome may influence immune checkpoint inhibitor (ICI) efficacy, but its association with immune-related adverse events (irAEs) is less well studied. In this prospective cohort study, we assessed whether gut microbiome composition at start, or changes during ICI, are associated with severe irAEs. METHODS: Stool samples of cancer patients treated with anti-PD-1 ± anti-CTLA-4 were analyzed using 16S rRNA gene sequencing and metagenomic shotgun sequencing. Differences in alpha and beta diversity between patients with and without severe irAE were assessed, as well as differential relative abundance (RA) of taxa, MetaCyc pathways, and seven prespecified literature-based bacterial groups including pathobionts and Ruminococcaceae. FINDINGS: We analyzed 497 samples of 195 patients before and soon after starting ICI, at severe irAE onset and after starting immunosuppression. Mean RA of the pathobionts group was significantly higher in patients who developed a severe irAE (8.2 %) compared to those who did not (4.8 %; odds ratio 1.40; 95 %CI 1.07-1.87) at baseline, and also early during ICI treatment and at severe irAE onset. A significantly stronger decrease in RA of Ruminococcaceae after starting ICI was observed in patients who developed a severe irAE compared to those who did not. RAs of Ruminococcaceae, the genus Ruminococcus, and the species R. bromii and R. callidus were significantly lower at severe irAE onset compared to other time points. INTERPRETATION: Gut microbiome dysbiosis signaled by higher RA of pathobionts and decrease in RA of Ruminococcaceae may predispose to severe irAEs.
Document Type: article in journal/newspaper
File Description: text/plain
Language: English
ISSN: 0959-8049
Relation: https://dspace.library.uu.nl/handle/1874/460104
Availability: https://dspace.library.uu.nl/handle/1874/460104
Rights: info:eu-repo/semantics/OpenAccess
Accession Number: edsbas.B0A637EC
Database: BASE